bromodeoxyuridine has been researched along with alvocidib in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bravo, R; Bruna, A; Caelles, C; Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jorda, EG; Pallàs, M; Pubill, D; Verdaguer, E | 1 |
Camins, A; Canudas, AM; Jiménez, A; Jordà, EG; Pallàs, M; Sureda, FX; Verdaguer, E | 1 |
Bosco, MC; Melillo, G; Pastorino, S; Pezzolo, A; Puppo, M; Varesio, L | 1 |
Basso, G; Bonvini, P; Monaco, G; Mussolin, L; Pigazzi, M; Rosolen, A; Zorzi, E | 1 |
Denvir, MA; Matrone, G; Mullins, JJ; Tucker, CS | 1 |
5 other study(ies) available for bromodeoxyuridine and alvocidib
Article | Year |
---|---|
Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Anthracenes; Anti-Bacterial Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Count; Cell Survival; Cells, Cultured; Cerebellum; Chromatin; Colchicine; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Flavonoids; Flow Cytometry; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Kainic Acid; MAP Kinase Kinase 4; Microtubules; Minocycline; Mitogen-Activated Protein Kinase Kinases; Neurons; Neuroprotective Agents; Piperidines; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Time Factors; Tubulin | 2003 |
Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment.
Topics: Animals; Bromodeoxyuridine; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cell Survival; Cells, Cultured; Cerebellum; DNA-Binding Proteins; Drug Interactions; E2F Transcription Factors; E2F1 Transcription Factor; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Flavonoids; Kainic Acid; Neurons; Neuroprotective Agents; Piperidines; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Transcription Factors; Up-Regulation | 2004 |
Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation.
Topics: Apoptosis; Bromodeoxyuridine; Caspases; Cell Hypoxia; Cell Survival; Cyclin-Dependent Kinases; Cytochromes c; DNA; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flavonoids; G1 Phase; G2 Phase; Genes, myc; Growth Inhibitors; Humans; Hypoxia; In Situ Nick-End Labeling; Neuroblastoma; Piperidines; Proto-Oncogene Mas; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2004 |
The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity.
Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Separation; Cell Survival; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large-Cell, Anaplastic; Piperidines; Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Subcellular Fractions; Time Factors | 2009 |
Effects of Cyclin Dependent Kinase 9 inhibition on zebrafish larvae.
Topics: Animals; Bromodeoxyuridine; Cell Death; Cell Proliferation; Cyclin-Dependent Kinase 9; Embryo, Nonmammalian; Flavonoids; Immunohistochemistry; Kaplan-Meier Estimate; Larva; Morpholinos; Phenotype; Piperidines; Protein Kinase Inhibitors; Survival Analysis; Zebrafish | 2016 |